Biosensors: new approaches in drug discovery

被引:105
|
作者
Keusgen, M [1 ]
机构
[1] Univ Bonn, Inst Pharmazeut Biol, D-53115 Bonn, Germany
关键词
D O I
10.1007/s00114-002-0358-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The development of biosensors for analytical purposes has attracted a great deal of attention in recent years. A biosensor is defined as an analytical device consisting of a biological component (e.g., enzyme, antibody, entire cell, DNA) and a physical transducer (e.g., electrode, optical device). Biosensors are mostly designed for routine analysis, such as clinical diagnosis, quality control of food, in-process control of fermentations, and in environmental analysis. Many of these sensors are also suitable for screening purposes in order to find new drugs. Such systems should yield information either about compounds with known bioactivity or about the bioactivity of samples with known or unknown chemical composition. Biosensors intended for the latter purpose are essentially based on whole cells carrying receptors and ion channels at their surfaces. Miniaturization of structures, primarily based on silicon, allows integration of many sensors into arrays, which may be suitable for the screening of natural and chemical products as well as combinatorial libraries. Until now, no commercially available sensors of this kind exist but they are expected in the near future. Different biosensors, based on enzymes, antibodies, cells, artificial membranes and entire animal tissues, which can be used in drug discovery and may lead to efficient screening systems in the future, are described in this review.
引用
收藏
页码:433 / 444
页数:12
相关论文
共 50 条
  • [31] The decline of antibiotic era - New approaches for antibacterial drug discovery
    Jagusztyn-Krynicka, Elzbieta K.
    Wyszynska, Agnieszka
    POLISH JOURNAL OF MICROBIOLOGY, 2008, 57 (02) : 91 - 98
  • [32] Integrative approaches for drug discovery
    Horowitz, D
    NEUROPEPTIDES, 2006, 40 (02) : 152 - 152
  • [33] Computational Approaches for Drug Discovery
    Brogi, Simone
    MOLECULES, 2019, 24 (17):
  • [34] Genomics approaches to drug discovery
    Reidhaar-Olson, JF
    Rhees, BK
    Hammer, J
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2001, 84 : 110 - 119
  • [35] Proteomics approaches in drug discovery
    Figeys, D
    ANALYTICAL CHEMISTRY, 2002, 74 (15) : 413A - 419A
  • [36] INVITRO APPROACHES TO DRUG DISCOVERY
    HAUBRICH, DR
    IN VITRO TOXICOLOGY : NEW DIRECTIONS, 1989, 7 : 3 - 10
  • [37] Computational Approaches for Drug Discovery
    Hung, Che-Lun
    Chen, Chi-Chun
    DRUG DEVELOPMENT RESEARCH, 2014, 75 (06) : 412 - 418
  • [38] Network approaches to drug discovery
    Chandra, Nagasuma
    Padiadpu, Jyothi
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (01) : 7 - 20
  • [39] Genomic approaches to drug discovery
    Ricke, Darrell O.
    Wang, Shaowen
    Cai, Richard
    Cohen, Dalia
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (04) : 303 - 308
  • [40] Fungal Drug Discovery for Chronic Disease: History, New Discoveries and New Approaches
    Prescott, Thomas A. K.
    Hill, Rowena
    Mas-Claret, Eduard
    Gaya, Ester
    Burns, Edie
    BIOMOLECULES, 2023, 13 (06)